The glyoxalase system of malaria parasites-Implications for cell biology and general glyoxalase research

Seminars in Cell and Developmental Biology

Volumn 22, Issue 3, 2011, Pages 262-270

  Urscher, Miriam ^a   Alisch, Romy ^a   Deponte, Marcel ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Apicoplast; Enzyme catalysis; Glyoxalase; Malaria; Methylglyoxal

Indexed keywords

DIMER; GLUCOSE; GLUTATHIONE; GLYOXALASE; HYDROXYACYLGLUTATHIONE HYDROLASE; ISOENZYME; LACTIC ACID; LACTOYLGLUTATHIONE LYASE; METAL ION; METHYLGLYOXAL; MONOMER;

ALLOSTERISM; APICOPLAST; CATALYSIS; CELLULAR DISTRIBUTION; CYTOLOGY; CYTOPLASM; DETOXIFICATION; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; ERYTHROCYTE; GLUCOSE INTAKE; GLYCOLYSIS; HOST PARASITE INTERACTION; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM; PLASMODIUM FALCIPARUM; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

VERTEBRATA;

EID: 79955956732     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.02.003     Document Type: Review

References (85)

1. World malaria report 2009. World Health Organization. http://www.who.int/malaria.
2. Kappe S.H., Vaughan A.M., Boddey J.A., Cowman A.F. That was then but this is now: malaria research in the time of an eradication agenda. Science 2010, 328:862-866.
3. Cox F.E. History of the discovery of the malaria parasites and their vectors. Parasit Vectors 2010, 3:5.
4. Tuteja R. Malaria - an overview. FEBS J 2007, 274:4670-4679.
5. Wells T.N., Burrows J.N., Baird J.K. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol 2010, 26:145-151.
6. Hoffman S.L., Billingsley P.F., James E., Richman A., Loyevsky M., Li T., et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 2010, 6:97-106.
7. Enserink M. Malaria's drug miracle in danger. Science 2010, 328:844-846.
8. Paaijmans K.P., Blanford S., Bell A.S., Blanford J.I., Read A.F., Thomas M.B. Influence of climate on malaria transmission depends on daily temperature variation. Proc Natl Acad Sci USA 2010, 107:15135-15139.
9. Wilson M.E., Freedman D.O. Etiology of travel-related fever. Curr Opin Infect Dis 2007, 20:449-453.
10. Zoller T., Naucke T.J., May J., Hoffmeister B., Flick H., Williams C.J., et al. Malaria transmission in non-endemic areas: case report, review of the literature and implications for public health management. Malar J 2009, 8:71.
11. Neuberg C. The destruction of lactic aldehyde and methylglyoxal by animal organs. Biochem Z 1913, 49:502-506.
12. Dakin H.D., Dudley H.W. On glyoxalase. J Biol Chem 1913, 14:423-431.
13. Lohmann K. Beitrag zur enzymatischen Umwandlung von syntetischem Methylglyoxal in Milchsäure. Biochem Z 1932, 254:332-354.
14. Jowett M., Quastel J.H. The glyoxalase activity of the red blood cell: the function of glutathione. Biochem J 1933, 27:486-498.
15. Racker E. The mechanism of action of glyoxalase. J Biol Chem 1951, 190:685-696.
16. Vander Jagt D.L. Glutathione: chemical, biochemical, and medical aspects 1989, 597-641. Wiley InterScience, New York. D. Dolphin, R. Poulson, O. Avramovic (Eds.).
17. Thornalley P.J. The glyoxalase system in health and disease. Mol Aspects Med 1993, 14:287-371.
18. Greig N., Wyllie S., Patterson S., Fairlamb A.H. A comparative study of methylglyoxal metabolism in trypanosomatids. FEBS J 2009, 276:376-386.
19. Wendler A., Irsch T., Rabbani N., Thornalley P.J., Krauth-Siegel R.L. Glyoxalase II does not support methylglyoxal detoxification but serves as a general trypanothione thioesterase in African trypanosomes. Mol Biochem Parasitol 2009, 163:19-27.
20. Szent-Györgyi A., Egyud L.G., McLaughlin J.A. Keto-aldehyde and cell division. Science 1967, 55:539-541.
21. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 2007, 282:31038-31045.
22. Kawatani M., Okumura H., Honda K., Kanoh N., Muroi M., Dohmae N., et al. The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc Natl Acad Sci USA 2008, 105:11691-11696.
23. Thornalley P.J., Ladan M.J., Ridgway S.J., Kang Y. Antitumor activity of S-(p-bromobenzyl)glutathione diesters in vitro: a structure-activity study. J Med Chem 1996, 39:3409-3411.
24. Kavarana M.J., Kovaleva E.G., Creighton D.J., Wollman M.B., Eiseman J.L. Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum. J Med Chem 1999, 42:221-228.
25. Thornalley P.J. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabol Drug Interact 2008, 23:125-150.
26. More S.S., Vince R. Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors. J Med Chem 2009, 52:4650-4656.
27. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
28. Nagaraj R.H., Shipanova I.N., Faust F.M. Protein cross-linking by the Maillard reaction Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J Biol Chem 1996, 271:19338-19345.
29. Frye E.B., Degenhardt T.P., Thorpe S.R., Baynes J.W. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 1998, 273:18714-18719.
30. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999, 344:109-116.
31. Kalapos M.P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 1999, 110:145-175.
32. Oya T., Hattori N., Mizuno Y., Miyata S., Maeda S., Osawa T., Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 1999, 274:18492-18502.
33. Thornalley P.J., Waris S., Fleming T., Santarius T., Larkin S.J., Winklhofer-Roob B.M., et al. Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance. Nucleic Acids Res 2010, 38:5432-5442.
34. Gomes R., Sousa Silva M., Quintas A., Cordeiro C., Freire A., Pereira P., et al. Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. Biochem J 2005, 385:339-345.
35. Miller A.G., Smith D.G., Bhat M., Nagaraj R.H. Glyoxalase I is critical for human retinal capillary. pericyte survival under hyperglycemic conditions. J Biol Chem 2006, 281:11864-11871.
36. Brouwers O., Niessen P.M., Ferreira I., Miyata T., Scheffer P.G., Teerlink T., et al. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation endproducts and oxidative stress in diabetic rats. J Biol Chem 2011, 286:1374-1380.
37. Sherman I.W. Biochemistry of Plasmodium (malarial parasites). Microbiol Rev 1979, 43:453-495.
38. Scheibel L.W., Pflaum W.K. Carbohydrate metabolism in Plasmodium knowlesi. Comp Biochem Physiol 1970, 37:543-553.
39. Shakespeare P.G., Trigg P.I., Kyd S.I., Tappenden L. Glucose metabolism in the simian malaria parasite Plasmodium knowlesi: activities of the glycolytic and pentose phosphate pathways during the intraerythrocytic cycle. Ann Trop Med Parasitol 1979, 73:407-415.
40. Olszewski K.L., Mather M.W., Morrisey J.M., Garcia B.A., Vaidya A.B., Rabinowitz J.D., Llinás M. Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 2010, 466:774-778.
41. Pfaller M.A., Krogstad D.J., Parquette A.R., Nguyen-Dinh P. Plasmodium falciparum: stage-specific lactate production in synchronized cultures. Exp Parasitol 1982, 54:391-396.
42. Vander Jagt D.L., Hunsaker L.A., Campos N.M., Baack B.R. d-Lactate production in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 1990, 42:277-284.
43. Thornalley P.J. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 1988, 254:751-755.
44. Aurrecoechea C., Brestelli J., Brunk B.P., Dommer J., Fischer S., Gajria B., et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res 2009, 37:D539-D543.
45. Becker K., Tilley L., Vennerstrom J.L., Roberts D., Rogerson S., Ginsburg H. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 2004, 34:163-189.
46. Loidl-Stahlhofen A., Spiteller G. α-Hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta 1994, 1211:156-160.
47. Francis S.E., Sullivan D.J., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 1997, 51:97-123.
48. Liu J., Istvan E.S., Gluzman I.Y., Gross J., Goldberg D.E. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc Natl Acad Sci USA 2006, 103:8840-8845.
49. Akoachere M., Iozef R., Rahlfs S., Deponte M., Mannervik B., Creighton D.J., et al. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts. Biol Chem 2005, 386:41-52.
50. Urscher M., Przyborski J.M., Imoto M., Deponte M. Distinct subcellular localization in the cytosol and apicoplast, unexpected dimerization and inhibition of Plasmodium falciparum glyoxalases. Mol Microbiol 2010, 76:92-103.
51. Becker K., Gui M., Traxler A., Kirsten C., Schirmer R.H. Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione. Histochemistry 1994, 102:389-395.
52. Becker K., Rahlfs S., Nickel C., Schirmer R.H. Glutathione-functions and metabolism in the malarial parasite Plasmodium falciparum. Biol Chem 2003, 384:551-566.
53. Aronsson A.C., Tibbelin G., Mannervik B. Purification of glyoxalase I from human erythrocytes by the use of affinity chromatography and separation of the three isoenzymes. Anal Biochem 1979, 92:390-393.
54. Schimandle C.M., Vander Jagt D.L. Isolation and kinetic analysis of the multiple forms of glyoxalase-I from human erythrocytes. Arch Biochem Biophys 1979, 195:261-268.
55. Allen R.E., Lo T.W., Thornalley P.J. A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies. J Protein Chem 1993, 12:111-119.
56. Ball J.C., Vander Jagt D.L. Purification of S-2-hydroxyacylglutathione hydrolase (glyoxalase II) from rat erythrocytes. Anal Biochem 1979, 98:472-477.
57. Allen R.E., Lo T.W., Thornalley P.J. Purification and characterisation of glyoxalase II from human red blood cells. Eur J Biochem 1993, 213:1261-1267.
58. Cameron A.D., Olin B., Ridderström M., Mannervik B., Jones T.A. Crystal structure of human glyoxalase I-evidence for gene duplication and 3D domain swapping. EMBO J 1997, 16:3386-3395.
59. Cordell P.A., Futers T.S., Grant P.J., Pease R.J. The human hydroxyacylglutathione hydrolase (HAGH) gene encodes both cytosolic and mitochondrial forms of glyoxalase II. J Biol Chem 2004, 279:28653-28661.
60. Board P.G. Genetic polymorphism of human erythrocyte glyoxalase II. Am J Hum Genet 1980, 32:690-694.
61. Cameron A.D., Ridderström M., Olin B., Mannervik B. Crystal structure of human glyoxalase II and its complex with a glutathione thiolester substrate analogue. Structure 1999, 7:1067-1078.
62. Uotila L. Purification and characterization of S-2-hydroxyacylglutathione hydrolase (glyoxalase II) from human liver. Biochemistry 1973, 12:3944-3951.
63. Iozef R., Rahlfs S., Chang T., Schirmer H., Becker K. Glyoxalase I of the malarial parasite Plasmodium falciparum: evidence for subunit fusion. FEBS Lett 2003, 554:284-288.
64. Deponte M., Sturm N., Mittler S., Harner M., Mack H., Becker K. Allosteric coupling of two different functional active sites in monomeric Plasmodium falciparum glyoxalase I. J Biol Chem 2007, 282:28419-28430.
65. Urscher M., Deponte M. Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis. Biol Chem 2009, 390:1171-1183.
66. Furuya T., Kessler P., Jardim A., Schnaufer A., Crudder C., Parsons M. Glucose is toxic to glycosome-deficient trypanosomes. Proc Natl Acad Sci USA 2002, 99:14177-14182.
67. Lim L., McFadden G.I. The evolution, metabolism and functions of the apicoplast. Philos Trans R Soc Lond B Biol Sci 2010, 365:749-763.
68. Fleige T., Fischer K., Ferguson D.J., Gross U., Bohne W. Carbohydrate metabolism in the Toxoplasma gondii apicoplast: localization of three glycolytic isoenzymes, the single pyruvate dehydrogenase complex, and a plastid phosphate translocator. Eukaryot Cell 2007, 6:984-996.
69. Fairfield A.S., Meshnick S.R., Eaton J.W. Malaria parasites adopt host cell superoxide dismutase. Science 1983, 221:764-766.
70. Fairfield A.S., Abosch A., Ranz A., Eaton J.W., Meshnick S.R. Oxidant defense enzymes of Plasmodium falciparum. Mol Biochem Parasitol 1988, 30:77-82.
71. Koncarevic S., Rohrbach P., Deponte M., Krohne G., Prieto J.H., Yates J., et al. The malarial parasite Plasmodium falciparum imports the human protein peroxiredoxin 2 for peroxide detoxification. Proc Natl Acad Sci USA 2009, 106:13323-13328.
72. Griffis C.E., Ong L.H., Buettner L., Creighton D.J. Nonstereospecific substrate usage by glyoxalase I. Biochemistry 1983, 22:2945-2951.
73. Landro J.A., Brush E.J., Kozarich J.W. Isomerization of (R)- and (S)-glutathiolactaldehydes by glyoxalase I: the case for dichotomous stereochemical behavior in a single active site. Biochemistry 1992, 31:6069-6077.
74. Rae C., O'Donoghue S.I., Bubb W.A., Kuchel P.W. Stereospecificity of substrate usage by glyoxalase 1: nuclear magnetic resonance studies of kinetics and hemithioacetal substrate conformation. Biochemistry 1994, 33:3548-3559.
75. Su Z., Sukdeo N., Honek J.F. 15N-1H HSQC NMR evidence for distinct specificity of two active sites in Escherichia coli glyoxalase I. Biochemistry 2008, 47:13232-13241.
76. Poole L.B., Nelson K.J. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol 2008, 12:18-24.
77. Groeger G., Quiney C., Cotter T.G. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 2009, 11:2655-2671.
78. Flohé L. Changing paradigms in thiology from antioxidant defense toward redox regulation. Methods Enzymol 2010, 473:1-39.
79. Schilling O., Wenzel N., Naylor M., Vogel A., Crowder M., Makaroff C., Meyer-Klaucke W. Flexible metal binding of the metallo-beta-lactamase domain: glyoxalase II incorporates iron, manganese, and zinc in vivo. Biochemistry 2003, 42:11777-11786.
80. Marasinghe G.P., Sander I.M., Bennett B., Periyannan G., Yang K.W., Makaroff C.A., Crowder M.W. Structural studies on a mitochondrial glyoxalase II. J Biol Chem 2005, 280:40668-40675.
81. Pastrana-Mena R., Dinglasan R.R., Franke-Fayard B., Vega-Rodríguez J., Fuentes-Caraballo M., Baerga-Ortiz A., et al. Glutathione reductase-null malaria parasites have normal blood stage growth but arrest during development in the mosquito. J Biol Chem 2010, 285:27045-27056.
82. Buchholz K., Putrianti E.D., Rahlfs S., Schirmer R.H., Becker K., Matuschewski K. Molecular genetics evidence for the in vivo roles of the two major NADPH-dependent disulfide reductases in the malaria parasite. J Biol Chem 2010, 285:37388-37395.
83. Sullivan D.J., Gluzman I.Y., Russell D.G., Goldberg D.E. On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci USA 1996, 93:11865-11870.
84. Thornalley P.J., Edwards L.G., Kang Y., Wyatt C., Davies N., Ladan M.J., Double J. Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo Inhibition of glyoxalase I and induction of apoptosis. Biochem Pharmacol 1996, 51:1365-1372.
85. Thornalley P.J., Strath M., Wilson R.J. Antimalarial activity in vitro of the glyoxalase I inhibitor diester S-p-bromobenzylglutathione diethyl ester. Biochem Pharmacol 1994, 47:418-420.